rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
2
|
pubmed:dateCreated |
1994-6-28
|
pubmed:abstractText |
To study the reduction of RB90740 (1), a fused pyrazine mono-N-oxide that has an oxic:hypoxic cytotoxicity ratio of > 10 in a range of murine and human tumor cells in vitro.
|
pubmed:grant |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0360-3016
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:day |
15
|
pubmed:volume |
29
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
333-7
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:8195029-Animals,
pubmed-meshheading:8195029-Antineoplastic Agents,
pubmed-meshheading:8195029-Cell Hypoxia,
pubmed-meshheading:8195029-Humans,
pubmed-meshheading:8195029-Hydrogen-Ion Concentration,
pubmed-meshheading:8195029-Mice,
pubmed-meshheading:8195029-Oxidation-Reduction,
pubmed-meshheading:8195029-Photochemistry,
pubmed-meshheading:8195029-Pyrazines,
pubmed-meshheading:8195029-Tumor Cells, Cultured
|
pubmed:year |
1994
|
pubmed:articleTitle |
Radiolytic and photochemical reduction of the hypoxic cytotoxin 1,2-dihydro-8-(4-methylpiperazinyl)-4-phenylimidazo [1,2-a] pyrido [3,2-e] pyrazine 5-oxide (RB90740) and a potential mechanism for hypoxia-selective toxicity.
|
pubmed:affiliation |
MRC Radiobiology Unit, Chilton, Didcot, Oxon, UK.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|